TSH Board of Directors Approved Financial Statements
For the Six Months Ended June 30, 2022
Date of events
2022/08/04
To which item it meets
paragraph 31
Statement
1.Date of the board of directors submitted or approved:2022/08/04
2.Date of the audit committee approved:2022/08/04
3.Start and end dates of financial reports or unaudited financial
information of the reporting period(XXXX/XX/XX~XXXX/XX/XX):
2022/01/01-2022/06/30
4.Operating revenue accumulated from 1/1 to end of the period
(thousand NTD):230,068
5.Gross profit (loss) from operations accumulated from 1/1 to end of
the period (thousand NTD):136,923
6.Net operating income (loss) accumulated from 1/1 to end of the period
(thousand NTD):39,413
7.Profit (loss) before tax accumulated from 1/1 to end of the period
(thousand NTD):44,618
8.Profit (loss) accumulated from 1/1 to end of the period
(thousand NTD):35,699
9.Profit (loss) during the period attributable to owners of parent
accumulated from 1/1 to end of the period (thousand NTD):35,699
10.Basic earnings (loss) per share accumulated from 1/1 to end of
the period (NTD):0.93
11.Total assets end of the period (thousand NTD):1,178,557
12.Total liabilities end of the period
(thousand NTD):124,832
13.Equity attributable to owners of parent end of the
period (thousand NTD):1,053,725
14.Any other matters that need to be specified:None
Attachments
Original Link
Original Document
Permalink
Disclaimer
TSH Biopharm Corporation Ltd. published this content on 04 August 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 04 August 2022 09:46:03 UTC.
Tsh biopham corporation ltd. is a Taiwan-based company principally engaged in the manufacturing and distribution of medical preparations. The Company primarily provides medicines for cardiovascular, including Amtrel, Rytmonorm, Licodin, Isormol and ISOPTIN SR; medicines for intestines and stomach, including MOPRIDE, Catilon, Gastro-Timelet and Ribarin, and medicines for central nervous, including Aleviatin, Lonine and Lacoxa SR. The Company distributes its products mainly in domestic markets.
TSH BIOPHARM CORPORATION LIMITED 